Journal of Urology

Papers
(The H4-Index of Journal of Urology is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Editorial Comment387
Editorial Comment257
Reflections on Diversity, Equity, and Inclusion in Medical Publishing: The Journal of Urology ® HEAD Table237
MP04-06 NOVEL CONTIGUOUS GENE DISORDER OF PKD1 , TSC2 AND NTHL1 LEADING TO CORRESPONDING KIDNEY DISEASES AN229
Kidney Cancer: Basic Research & Pathophysiology I (MP04)198
Assessing “Spin” in Urology Randomized Controlled Trials With Statistically Nonsignificant Primary Outcomes. Letter.154
Reply by Authors153
Reply by Authors146
V04-12 ROBOT-ASSISTED PARTIAL NEPHRECTOMY USING INTRA-ARTERIAL RENAL HYPOTHERMIA FOR HIGHLY COMPLEX ENDOPHYTIC OR HILAR TUMORS124
Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance. Letter.123
Editorial Comment121
MP78-19 PREOPERATIVE BLADDER MECHANICS FORECAST INDIVIDUALIZED ARTIFICIAL URINARY SPHINCTER LONGEVITY119
Editorial Comment114
Selecting Patients with Favorable Risk, Grade Group 2 Prostate Cancer for Active Surveillance—Does Magnetic Resonance Imaging Have a Role?102
PD60-08 OUTCOMES OF SALVAGE ROBOTIC-ASSISTED RADICAL PROSTATECTOMY COMPARING PATIENTS WITH PRIMARY FOCAL THERAPY VERSUS WHOLE GLAND ABLATION: A MULTICENTRIC COLLABORATIVE DATA98
MP20-07 NPTX1 IS A NOVEL SERUM BIOMARKER INDUCED BY ARPI TREATED PROSTATE CANCER AND ENRICHED IN LINEAGE PLASTICITY WITH BRN2 HIGH88
PD34-03 INTRAOPERATIVE TRANEXAMIC ACID IN RADICAL CYSTECTOMY: IMPACT ON BLEEDING, THROMBOEMBOLISM, AND CANCER-SPECIFIC SURVIVAL83
Letter: Miniaturized Percutaneous Nephrolithotomy With Vacuum-Assisted Access Sheaths for Treatment of Nephrolithiasis76
Reply: The AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder70
Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome. Reply.66
LBA02-07 SEX-DEPENDENT DISTRIBUTION OF PATHOGENIC GERMLINE VARIANTS IN BLADDER CANCER: A POPULATION-BASED ANALYSIS OF 400,000 INDIVIDUALS60
Expression of Concern: Lymph Node Mapping in Patients with Penile Cancer Undergoing Pelvic Lymph Node Dissection59
Expression of Concern: Sperm DNA Damage and Semen Quality Impairment After Treatment With Selective Serotonin Reuptake Inhibitors Detected Using Semen Analysis and Sperm Chromatin Structure Assay57
Expression of Concern: Penile Fractures: Evaluation, Therapeutic Approaches and Long-Term Results56
Expression of Concern: Ureterovaginal Fistula After Vaginal Delivery55
Expression of Concern: Comparison of Vitamin E and Propionyl-L-Carnitine, Separately or in Combination, in Patients With Early Chronic Peyronie’s Disease: A Double-Blind, Placebo Controlled, Randomize54
PD43-07 CLINICAL CHARACTERISTICS ASSOCIATED WITH HIGH-RISK CANCER-PREDISPOSITION GERMLINE MUTATIONS IN PATIENTS WITH UROTHELIAL CARCINOMA: IMPLICATIONS FOR GENETIC TESTING48
Gemcitabine Versus Bacillus Calmette-Guérin for Intravesical Therapy in Treatment-Naïve Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer48
MP38-07 UPGRADING ON PER PROTOCOL VS FOR CAUSE SURVEILLANCE PROSTATE BIOPSIES: AN OPPORTUNITY TO DECREASING THE BURDEN OF ACTIVE SURVEILLANCE47
MP13-08 IMPACT OF PATIENT, SURGICAL, AND PERIOPERATIVE FACTORS ON DISCHARGE DISPOSITION AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER46
MP62-03 CONFIRMATORY TESTING OUTCOMES IN ACTIVE SURVEILLANCE: RESULTS FROM THE MICHIGAN UROLOGICAL SURGERY IMPROVEMENT COLLABORATIVE (MUSIC)46
MP45-10 PERSPECTIVES ON THE ROLE OF BIOPSY FOR MANAGEMENT OF T1 RENAL MASSES: RESULTS FROM TWO QUALITY IMPROVEMENT COLLABORATIVES46
PD26-08 ERECTILE DYSFUNCTION IN MEN WITH PREDIABETES AND TYPE 2 DIABETES: THE DIABETES PREVENTION PROGRAM OUTCOMES STUDY (DPPOS)46
PD54-05 STENT OMISSION IN PRESTENTED PATIENTS UNDERGOING URETEROSCOPY DECREASES UNPLANNED HEALTHCARE UTILIZATION46
PD11-06 BASELINE PSA BELOW 1.0 NG/ML, AND THEN? VERIFICATION OF THE EAU 2021 POSITION AND RECOMMENDATION ON RISK-ADAPTED EARLY DETECTION USING ERSPC ROTTERDAM DATA WITH MORE THAN 20 YEARS OF DETAILED 45
MP62-14 THE INFLUENCE OF MAGNETIC RESONANCE IMAGING, GENOMIC CLASSIFIERS, AND POST-MAGNETIC RESONANCE IMAGING BIOPSY RESULTS ON SHARED-DECISION MAKING IN NEWLY DIAGNOSED FAVORABLE RISK PROSTATE CANCER45
MP30-10 UROLOGICAL CANCERS DURING COVID-19: ANALYSES OF SHORT-TERM OUTCOMES FROM THE COVIDSURG-CANCER STUDY45
PD26-10 COMPARISON OF INTRAVESICAL THERAPY AND SURGERY AS TREATMENT OPTIONS FOR RECURRENT BLADDER CANCER (CISTO): UPDATE ON AN ONGOING MULTICENTER PRAGMATIC STUDY42
MP33-08 OPIOID PRESCRIBING PATTERNS AND POST-PROSTATECTOMY READMISSION41
PD11-03 SURGEON SKILL IS ASSOCIATED WITH POSITIVE SURGICAL MARGINS IN ROBOT-ASSISTED PARTIAL NEPHRECTOMY: RESULTS OF A VIDEO-BASED EVALUATION40
0.15835690498352